Merit Medical Systems (NASDAQ:MMSI) (NASDAQ:MMSI), founded in 1987 and headquartered in South Jordan, Utah, is a global developer, manufacturer and marketer of medical devices and consumables. The company focuses on minimally invasive procedural equipment and solutions intended to improve clinical outcomes and reduce complications. Over more than three decades, Merit has expanded its product offerings to support a broad range of interventional cardiology, peripheral vascular, oncology and radiology procedures.
Merit’s product portfolio includes vascular access and diagnostic catheters, guidewires, introducer sheaths, fluid and contrast management systems, biopsy needles and ablation accessories. The company also produces specialty devices for urology, critical care and pregnancy-related applications, such as central venous catheter kits, hemodialysis connectors and fetal monitoring tools. Emphasizing continuous innovation, Merit invests in research and development to address the evolving needs of physicians and healthcare providers.
With operations spanning North America, Europe, Latin America and the Asia‐Pacific region, Merit maintains manufacturing facilities in the United States, Ireland, Colombia and Brazil, supported by a global distribution network. This footprint enables the company to serve large hospital systems, specialty clinics and physician offices worldwide. Merit also offers training and technical support to ensure proper device utilization and optimal patient care.
Under the leadership of founder and Executive Chairman Fred S. Lampropoulos, Merit’s management team is committed to quality, regulatory compliance and customer service. The company’s culture emphasizes collaboration, ethical conduct and continuous improvement. Through strategic partnerships and targeted acquisitions, Merit continues to strengthen its position in the interventional medical device market.
